These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 7579726)

  • 61. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines].
    Matsumoto Y; Takano H; Nagao S; Iglesias A; Fojo T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2265-9. PubMed ID: 9422071
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
    Danks MK; Schmidt CA; Deneka DA; Beck WT
    Cancer Commun; 1989; 1(2):101-9. PubMed ID: 2561733
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
    Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K
    Leukemia; 1996 Jul; 10(7):1177-80. PubMed ID: 8683999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
    Towatari M; Ito Y; Morishita Y; Tanimoto M; Kawashima K; Morishima Y; Andoh T; Saito H
    Cancer Res; 1990 Nov; 50(22):7198-202. PubMed ID: 1699657
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    Per SR; Mattern MR; Mirabelli CK; Drake FH; Johnson RK; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):17-25. PubMed ID: 3037302
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.
    Danks MK; Schmidt CA; Cirtain MC; Suttle DP; Beck WT
    Biochemistry; 1988 Nov; 27(24):8861-9. PubMed ID: 2853972
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines.
    Sugimoto Y; Tsukahara S; Oh-hara T; Liu LF; Tsuruo T
    Cancer Res; 1990 Dec; 50(24):7962-5. PubMed ID: 2174738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).
    Danks MK; Yalowich JC; Beck WT
    Cancer Res; 1987 Mar; 47(5):1297-301. PubMed ID: 3469013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
    Bertrand R; Sarang M; Jenkin J; Kerrigan D; Pommier Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6280-5. PubMed ID: 1933888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence of DNA topoisomerase II-dependent mechanisms of multidrug resistance in P388 leukemia cells.
    De Isabella P; Capranico G; Binaschi M; Tinelli S; Zunino F
    Mol Pharmacol; 1990 Jan; 37(1):11-6. PubMed ID: 2153905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
    Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Fisher LM
    Br J Cancer; 1993 Mar; 67(3):456-63. PubMed ID: 8382508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered DNA topoisomerase II in multidrug resistance.
    Beck WT; Danks MK; Wolverton JS; Granzen B; Chen M; Schmidt CA; Bugg BY; Friche E; Suttle DP
    Cytotechnology; 1993; 11(2):115-9. PubMed ID: 7764055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells.
    Deffie AM; Bosman DJ; Goldenberg GJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):6879-82. PubMed ID: 2555055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells.
    Khélifa T; Beck WT
    Biochem Pharmacol; 1999 Oct; 58(8):1247-57. PubMed ID: 10487526
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
    Chresta CM; Hall BF; Francis GE
    Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells.
    Fernandes DJ; Smith-Nanni C; Paff MT; Neff TA
    Cancer Res; 1988 Apr; 48(7):1850-5. PubMed ID: 3349463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
    Constantinou A; Henning-Chubb C; Huberman E
    Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
    Kerrigan D; Pommier Y; Kohn KW
    NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.